Henrik Rasmussen

Henrik Sandvad Rasmussen was the founder of Rasmussen Biotech & Pharma Consulting LLC (founded in 2009, where he held the title of President & Chief Executive Officer from 2009 to 2012) and Renibus Therapeutics, Inc. (founded in 2015, where he previously held the title of Director).
He is currently a Director at Neoprogen, Inc. Dr. Rasmussen's former positions include Global Study Director at Pfizer Central Research (1989-1994), Chief Medical Officer at Nabi Biopharmaceuticals and Alba Therapeutics Corp., Senior VP-Clinical Research & Regulatory Affairs at Ligand UK Ltd. (1994-1999), Chief Medical Officer at GenVec, Inc. (1999-2003), Vice President, Head-Medical & Regulatory Affairs at Novo-Nordisk Biochem, Inc. (2007-2009), Chief Medical Officer at Nabi Pharmaceuticals (2003-2007), Chief Medical Officer & Chief Scientific Officer at ZS Pharma, Inc. (2012-2016), and Chief Medical Officer at Allakos, Inc. (2017-2021).
Dr. Rasmussen received a doctorate degree from the University of Copenhagen in 1992.